HCM
GEVA

Highbridge Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Highbridge Capital Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,500
Closed -$472K – 1534
2014
Q2 		$472K Buy
+4,500
New +$383K 0.01% 755
2014
Q1 		– Sell
-4,700
Closed -$304K – 1406
2013
Q4 		$304K Buy
+4,700
New +$279K ﹤0.01% 837